Gene Expression Profiling of the Human Prostate Androgen Response Program
2002; Wiley; Volume: 23; Issue: 2 Linguagem: Inglês
10.1002/j.1939-4640.2002.tb02608.x
ISSN2047-2927
Autores Tópico(s)Advanced Proteomics Techniques and Applications
ResumoJournal of AndrologyVolume 23, Issue 2 p. 163-169 Free Access Gene Expression Profiling of the Human Prostate Androgen Response Program STACY M. MOORE, STACY M. MOORE Divisions of Human BiologySearch for more papers by this authorPETER S. NELSON, Corresponding Author PETER S. NELSON Divisions of Human Biology Clinical Research, The Fred Hutchinson Cancer Research Center, Seattle, Washington. Division of Human Biology, Fred Hutchinson Cancer Research Center, Mailstop D4-100, 1100 Fairview Ave N, Seattle, WA 98109-1024 (e-mail: [email protected]).Search for more papers by this author STACY M. MOORE, STACY M. MOORE Divisions of Human BiologySearch for more papers by this authorPETER S. NELSON, Corresponding Author PETER S. NELSON Divisions of Human Biology Clinical Research, The Fred Hutchinson Cancer Research Center, Seattle, Washington. Division of Human Biology, Fred Hutchinson Cancer Research Center, Mailstop D4-100, 1100 Fairview Ave N, Seattle, WA 98109-1024 (e-mail: [email protected]).Search for more papers by this author First published: 02 January 2013 https://doi.org/10.1002/j.1939-4640.2002.tb02608.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature. 1999; 402: 715–720. Adams MD, Kerlavage AR, Fleischmann RD, et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 1995; 377: 3–174. Amler LC, Agus DB, LeDuc C., et al. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer Xenograft model CWR22-R. Cancer Res. 2000; 60: 6134–6141. Baratta M., Grolli S., Poletti A., Ramoni R., Motta M., Tamanini C. Role of androgens in proliferation and differentiation of mouse mammary epithelial cell line HC11. J Endocrinol. 2000; 167: 53–60. Boguski MS, Lowe TM, Tolstoshev CM. DbEST-database for "expressed sequence tags". Nat Genet. 1993; 4: 332–333. Bonkhoff H., Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996; 28: 98–106. Bruckheimer EM, Kyprianou N. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinology. 2001; 142: 2419–2426. Chang GT, Blok LJ, Steenbeek M., Veldscholte J., Van Weerden WM, Van Steenbrugge GJ, Brinkmann AO. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res. 1997; 57: 4075–4081. Chee M., Yang R., Hubbell E., et al. Accessing genetic information with high-density DNA arrays. Science. 1996; 274: 610–614. Collett GP, Betts AM, Johnson MI, Pulimood AB, Cook S., Neal DE, Robson CN. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. Clin Cancer Res. 2000; 6: 3241–3248. Craft N., Chhor C., Tran C., et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. 1999; 59: 5030–5036. Cude KJ, Dixon SC, Guo Y., Lisella J., Figg WD. The androgen receptor: genetic considerations in the development and treatment of prostate cancer. J Mol Med. 1999; 77: 419–426. Culig Z., Hobisch A., Bartsch G., Klocker H. Androgen receptor—an update of mechanisms of action in prostate cancer. Urol Res. 2000; 28: 211–219. Culig Z., Hobisch A., Cronauer MV, Radmayr C., Trapman J., Hittmair A., Bartsch G., Klocker H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 1994; 54: 5474–5478. Culig Z., Hobisch A., Hittmair A., Peterziel H., Cato AC, Bartsch G., Klocker H. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate. 1998; 35: 63–70. Cunha GR, Donjacour AA, Cooke PS, Mee S., Bigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr Rev. 1987; 8: 338–362. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998; 12: 3343–3356. Djavan B., Waldert M., Seitz C., Marberger M. Insulin-like growth factors and prostate cancer. World J Urol. 2001; 19: 225–233. Freedman LP. Increasing the complexity of coactivation in nuclear receptor signaling. Cell. 1999; 97: 5–8. Freije JM, MacDonald NJ, Steeg PS. Nm23 and tumour metastasis: basic and translational advances. Biochem Soc Symp. 1998; 63: 261–271. Gleave M., Bruchovsky N., Goldenberg SL, Rennie P. Intermittent androgen suppression for prostate cancer: rationale and clinical experience. Eur Urol. 1998; 34: 37–41. Gygi SP, Rist B., Gerber SA, Turecek F., Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999a; 17: 994–999. Gygi SP, Rochon Y., Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999b; 19: 1720–1730. He WW, Sciavolino PJ, Wing J., et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics. 1997; 43: 69–77. Hobisch A., Eder IE, Putz T., Horninger W., Bartsch G., Klocker H., Culig Z. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 1998; 58: 4640–4645. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L.. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996; 10: 1167–1177. Huggins C., Hodges CV. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941; 1: 293–297. Isaacs JT, Lundmo PI, Berges R., Martikainen P., Kyprianou N., English HF. Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl. 1992; 13: 457–464. Janne OA, Palvimo JJ, Kallio P., Mehto M. Androgen receptor and mechanism of androgen action. Ann Med. 1993; 25: 83–89. Jenkins RE, Pennington SR. Arrays for protein expression profiling: towards a viable alternative to two-dimensional gel electrophoresis? Proteomics. 2001; 1: 13–29. Jenster G. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines. J Pathol. 2000; 191: 227–228. Klocker H., Culig Z., Kaspar F., Hobisch A., Eberle J., Reissigl A., Bartsch G. Androgen signal transduction and prostatic carcinoma. World J Urol. 1994; 12: 99–103. Koivisto P., Kolmer M., Visakorpi T., Kallioniemi OP. Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol. 1998; 152: 1–9. Korkmaz KS, Korkmaz CG, Ragnhildstveit E., Pretlow TG, Saatcioglu F. An efficient procedure for cloning hormone-responsive genes from a specific tissue. DNA Cell Biol. 2000; 19: 499–506. Kousteni S., Bellido T., Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001; 104: 719–730. Lash AE, Tolstoshev CM, Wagner L., Schuler GD, Strausberg RL, Riggins GJ, Altschul SF. SAGEmap: a public gene expression resource. Genome Res. 2000; 10: 1051–1060. Lee C., Sutkowski DM, Sensibar JA, et al. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology. 1995; 136: 796–803. Lennon GG, Lehrach H. Hybridization analyses of arrayed cDNA libraries. Trends Genet. 1991; 7: 314–317. Liang P., Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992; 257: 967–971. Lin B., Ferguson C., White JT, Wang S., Vessella R., True LD, Hood L., Nelson PS. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 1999; 59: 4180–4184. Lin B., White JT, Ferguson C., et al. PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12. Cancer Res. 2000; 60: 858–863. Lin B., White JT, Ferguson C., et al. Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium. Cancer Res. 2001; 61: 1611–1618. Ling MT, Chan KW, Choo CK. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. J Endocrinol. 2001; 170: 287–296. Lopaczynski W., Hruszkewycz AM, Lieberman R. Preprostatectomy: a clinical model to study stromal-epithelial interactions. Urology. 2001; 57: 194–199. Mann M., Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem. 2001; 70: 437–473. Migliaccio A., Castoria G., Di Domenico M., et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 2000; 19: 5406–5417. Nelson PS, Gan L., Ferguson C., Moss P., Gelinas R., Hood L., Wang K. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci USA. 1999; 96: 3114–3119. Nelson PS, Han D., Rochon Y., et al. Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics. Electrophoresis. 2000; 21: 1823–1831. Nguyen C., Rocha D., Granjeaud S., Baldit M., Bernard K., Naquet P., Jordan BR. Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics. 1995; 29: 207–216. Niu Y., Zhang J., Bai J., Yang H., Ma T. Proliferation and differentiation of prostatic stromal cells. BJU Int. 2001; 87: 386–393. O'Malley B. The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol. 1990; 4: 363–369. Schena M., Shalon D., Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995; 270: 467–470. Scheurle D., DeYoung MP, Binninger DM, Page H., Jahanzeb M., Narayanan R. Cancer gene discovery using digital differential display. Cancer Res. 2000; 60: 4037–4043. Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol. 1998; 65: 191–198. Ulrix W., Swinnen JV, Heyns W., Verhoeven G. Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP. J Biol Chem. 1998; 273: 4660–4665. Ulrix W., Swinnen JV, Heyns W., Verhoeven G. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP. Mol Cell Endocrinol. 1999a; 155: 69–76. Ulrix W., Swinnen JV, Heyns W., Verhoeven G. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett. 1999b; 455: 23–26. Velculescu VE, Madden SL, Zhang L., et al. Analysis of human transcriptomes. Nat Genet. 1999; 23: 387–388. Velculescu VE, Zhang L., Vogelstein B., Kinzler KW. Serial analysis of gene expression. Science. 1995; 270: 484–487. Wainstein MA, He F., Robinson D., et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 1994; 54: 6049–6052. Waltregny D., Leav I., Signoretti S., et al. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Mol Endocrinol. 2001; 15: 765–782. Wang Z., Tufts R., Haleem R., Cai X. Genes regulated by androgen in the rat ventral prostate. Proc Natl Acad Sci USA. 1997; 94: 12999–13004. Weinberger SR, Morris TS, Pawlak M. Recent trends in protein biochip technology. Pharmacogenomics. 2000; 1: 395–416. Wen Y., Hu MC, Makino K., Spohn B., Bartholomeusz G., Yan DH, Hung MC. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2000; 60: 6841–6845. Wodicka L., Dong H., Mittmann M., Ho MH, Lockhart DJ. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol. 1997; 15: 1359–1367. Xu LL, Shanmugam N., Segawa T., Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics. 2000; 66: 257–263. Xu LL, Su YP, Labiche R., Segawa T., Shanmugam N., McLeod DG, Moul JW, Srivastava S. Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer. 2001; 92: 322–328. Zhang L., Zhou W., Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B., Kinzler KW. Gene expression profiles in normal and cancer cells. Science. 1997; 276: 1268–7122. Citing Literature Volume23, Issue2March‐April 2002Pages 163-169 ReferencesRelatedInformation
Referência(s)